27 March 2022
We are celebrating with you, Australia!
Today we all heard the exciting news that Trikafta has been officially funded on the Pharmaceutical Benefits Scheme (PBS) in Australia, and will be available from Friday 1 April 2022.
Jo Armstrong, Chief Executive for Cystic Fibrosis Australia said, “Thank you to all parties who have listened to us to ensure that Trikafta was made available on the PBS as soon as possible.
This is a true victory for individuals living with CF and for their friends and families. As a community we have been fighting for Trikafta since prior to registration knowing how it could offer direct and tangible improvement in the lives of people with CF. Now, so many of our friends and family who are living with CF can now look forward to longer, more active, and more fulfilled lives with access to this game-changing medication.”
We are thrilled for our cystic fibrosis whanau across the ditch, lives are about to change – next step, New Zealand!